Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
Omada Health will present peer-reviewed research at the World Obesity and Weight Management Congress showing members of its GLP-1 Care Track lost more weight than GLP-1 users receiving usual care. In the 12-week study of 245 adults, Omada members lost 6.0% of starting body weight versus 3.3% for usual care, with roughly double the body fat reduction and better muscle mass retention; the findings were published in Diabetes, Obesity and Metabolism.
Key figures
- Weight loss omada
- 6.0% of starting body weight
- Participants omada
- 151
- Participants total
- 245
- Study duration weeks
- 12
- Weight loss usual care
- 3.3%
- Participants usual care
- 94
- Body fat reduction omada
- -3.3%
- Mental symptom reduction
- ~30% drop in depression and anxiety symptoms
- Muscle mass increase omada
- +0.6%
- Body fat reduction usual care
- -1.6%
- Muscle mass increase usual care
- +0.2%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.